SBI Securities’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

SBI Securities’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-165	Closed	-$561	–	4335
2025 Q2	$561	Hold	165	–	–	﹤0.01%	2921
2025 Q1	$465	Hold	165	–	–	﹤0.01%	2896
2024 Q4	$457	Buy	+165	New	+$538	﹤0.01%	2926

Other funds holding CSCI

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

SBI Securities's CSCI Position: Q3 2025 in Review

SBI Securities sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 165 shares — an estimated $561 sold.

SBI Securities first reported a position in CSCI in Q4 2024 and held it in 3 quarters. The position peaked at $561 in Q2 2025. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.

SBI Securities reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
SBI Securities sold 165 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $561.
SBI Securities first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2024 and held it in 3 quarters.
SBI Securities's COSCIENS Biopharma Inc. Common Stock position peaked at $561 in Q2 2025.
2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.

Based on SBI Securities's 13F filing for Q3 2025, filed 5 Nov 2025.